Niva Bupa Health Insurance Company opened lower at ₹80.20, compared with its previous close of ₹80.29. During today's session, the stock has traded between ₹77.70 and ₹80.20, with an average traded price of ₹78.69. It is currently showing a downward intraday trend.
An investment of ₹10,000 made 2 years ago in Niva Bupa Health Insurance Company is now worth
₹ 10,530.00
giving a profit of
₹ 530.00 (5.30%)
Note: Past profits do not guarantee future returns.
No analyst rating data available.
Today's Change
-2.35 (-2.93%)
Day High
₹80.20
Day Low
₹77.70
Day Open
₹80.20
Prev Close
₹80.29
Volume
4,03,344
Value Traded
₹3.17 Cr
1W Return
2.76%
1M Return
-2.49%
3M Return
-9.91%
6M Return
5.80%
1Y Return
-1.76%
Market Cap (₹ Cr.)
14,416
PE Ratio
85.40
PB Ratio
3.92
Dividend Yield
-
ROE
3.45%
ROCE
-2.90%
Book Value (₹)
20.48
Face Value (₹)
10.00
EPS (TTM)
-
Industry PE
-
Beta
-
Debt to Equity
-
1 Week
2.76%
6 Week
-
1 Month
-2.49%
3 Month
-9.91%
9 Month
-0.09%
No data available.
Niva Bupa approves redemption of ₹150 crore NCDs at par
Niva Bupa approved redemption of ₹150 crore NCDs at par on October 9, 2026. Record date set for November 2, 2026, due to original date falling on a holiday. Interest and principal payment scheduled for November 13, 2026. Debentures carry a 10.70% coupon rate and were issued in November 2021.
4 days agoNiva Bupa Health Insurance to hold virtual investor call on Sep 24
Niva Bupa Health Insurance Company Limited scheduled a virtual institutional investor call for September 24, 2026. The meeting involves sell-side and buy-side analysts starting at 6:00 pm IST. Management cited urgency as the reason for scheduling the call on short notice.
19 days agoAM Best upgrades Bupa Insurance credit ratings to A- with stable outlook
AM Best upgraded Bupa Insurance Company’s Financial Strength Rating to A- (Excellent) from B++. Long-Term Issuer Credit Rating raised to "a-" (Excellent) with a stable outlook assigned. Upgrade driven by very strong balance sheet, strongest BCAR capitalization, and parent support. Company generated annual pretax net operating gains over the last five years through mid-2026. Premium concentration remains in competitive Latin American private medical insurance segment.
25 days agoAM Best assigns A- financial strength rating to Niva Bupa
AM Best assigns A- Financial Strength Rating and aaa.IN National Scale Rating. Outlook is stable, reflecting strong BCAR capitalisation as of March 31, 2026. FY26 return on equity stands at 10.7%, offsetting a combined ratio of 102.0%. Ratings benefit from enhancement due to majority ownership by Bupa Group.
26 days agoNiva Bupa appoints Karan Bhatia as chief investment officer
Karan Bhatia appointed as chief investment officer effective September 16, 2026. Vikas Jain transitions from CIO to chief transformation officer. Bhatia brings over 18 years of investment experience to the role. Disclosure made under SEBI Listing Regulations Regulation 30.
27 days agoNiva Bupa Health Insurance receives '67 Leader' ESG rating from Niche99
Niche99 ESG Ratings assigned a '67 Leader' score to Niva Bupa for FY25 and FY26. The SEBI-registered agency based the rating on independent analysis of public domain data. Niva Bupa did not engage the rating agency for this specific assessment. Disclosure was filed under Regulation 30 of SEBI Listing Regulations.
27 days ago| Stock | LTP | Change % | Market Cap (Cr.) | PE | 1Y Return |
|---|---|---|---|---|---|
| ₹1,691.80 | +1.06% | ₹84,524.83 | 34.16 | -9.18% | |
| ₹319.05 | +0.90% | ₹55,974.13 | 6.25 | -16.88% | |
| ₹560.10 | -0.55% | ₹32,968.81 | 39.18 | +16.99% | |
| ₹191.38 | +2.33% | ₹31,539.42 | 39.65 | -0.77% | |
| ₹280.85 | +0.52% | ₹25,982.69 | 52.48 | -22.61% |
An investment of ₹10,000 made 2 years ago in Niva Bupa Health Insurance Company is now worth
₹ 10,530.00
giving a profit of
₹ 530.00 (5.30%)
Note: Past profits do not guarantee future returns.
